|
||
© The Rockefeller University Press,
0021-9525/2003/3/1151 $5.00
The Journal of Cell Biology, Volume 160, Number 7, 1151-1161
Article |
Intercellular calcium communication regulates platelet aggregation and thrombus growth
Address correspondence to Shaun P. Jackson, Australian Centre for Blood Diseases, Department of Medicine, Monash University, Box Hill Hospital, Arnold St., Box Hill, Melbourne, Victoria 3128, Australia. Tel.: 03-9895-0350. Fax: 03-9895-0332. E-mail: shaun.jackson{at}med.monash.edu.au
| Abstract |
|---|
|
|
|---|
The ability of platelets to form stable adhesion contacts with other activated platelets (platelet cohesion or aggregation) at sites of vascular injury is essential for hemostasis and thrombosis. In this study, we have examined the mechanisms regulating cytosolic calcium flux during the development of plateletplatelet adhesion contacts under the influence of flow. An examination of platelet calcium flux during platelet aggregate formation in vitro demonstrated a key role for intercellular calcium communication (ICC) in regulating the recruitment of translocating platelets into developing aggregates. We demonstrate that ICC is primarily mediated by a signaling mechanism operating between integrin
IIbß3 and the recently cloned ADP purinergic receptor P2Y12. Furthermore, we demonstrate that the efficiency by which calcium signals are propagated within platelet aggregates plays an important role in dictating the rate and extent of thrombus growth.
Key Words: blood platelets; cell adhesion; thrombosis; calcium signaling; integrin
IIbß3
The online version of this article includes supplemental material.
* Abbreviations used in this paper: GP, glycoprotein; ICC, intercellular calcium communication; TXA2, thromboxane A2; vWf, von Willebrand factor.
| Introduction |
|---|
|
|
|---|
Fibrillar collagen is one of the adhesive substrates contributing to the heightened thrombogenic potential of advanced atherosclerotic lesions (Baumgartner et al., 1977). Type I and III fibrillar collagens are amongst the most reactive of all vessel wall proteins, inducing potent platelet activation through one or more cell surface receptors, including integrin
2ß1 and glycoprotein (GP)* VI/Fc
R (for review see Clemetson and Clemetson, 2001). The ability of collagen to support platelet adhesion under conditions of high shear is dependent on a second adhesive protein, von Willebrand factor (vWf). A unique feature of vWf is its ability to support platelet adhesion under conditions of high shear flow, such as those encountered in the microcirculation and at sites of arterial stenosis. vWf engages two platelet adhesion receptors, the GPIb/V/IX receptor complex and integrin
IIbß3, wherein the vWfGPIb interaction serves to recruit platelets to the vessel wall while vWf binding to integrin
IIbß3 promotes platelet arrest (Savage et al., 1996).
Recent studies examining platelet thrombus formation under high shear conditions, using various in vitro and in vivo thrombosis models, have highlighted the important role of vWf in mediating both primary platelet adhesion and subsequent thrombus growth (Badimon et al., 1989; Savage et al., 1996; Denis et al., 1998; Goto et al., 1998; Savage et al., 1998; Mazzucato et al., 1999, Ruggeri et al., 1999; Tsuji et al., 1999; Kulkarni et al., 2000; Ni et al., 2000). Thus, the multistep adhesion mechanism described for primary platelet adhesion on vWf (Savage et al., 1996) also appears to be relevant for subsequent platelet aggregation (for review see Ruggeri, 2000). Recent intravital studies have confirmed the importance of the sequential interaction between vWf expressed on the platelet surface with GPIb and integrin
IIbß3 on flowing platelets for subsequent platelet cohesion (aggregation) and thrombus growth (Kulkarni et al., 2000; Ni et al., 2000; Denis et al., 2001). These studies have also highlighted the dynamic nature of platelet thrombus growth in vivo, in which the majority of platelets tethering to the luminal surface of thrombi translocate for a variable period of time before forming stationary adhesion contacts or detaching from the thrombus surface (Kulkarni et al., 2000). Unravelling the mechanisms regulating the transition from surface translocation is important, as the efficiency of this conversion is a key determinant regulating the rate and extent of thrombus growth.
The mechanisms regulating firm platelet adhesion on vWf under flow are poorly defined, although recent studies have suggested that outside-in signals from the adhesion receptors themselves may be sufficient to induce a sufficient level of integrin
IIbß3 activation to promote firm platelet adhesion independent of soluble agonists (Nesbitt et al., 2002). According to these studies, GPIb-dependent calcium transients initiate a low level of integrin
IIbß3 activation that is reinforced by integrin
IIbß3 outside-in signals promoting sustained calcium oscillations and firm platelet adhesion (Nesbitt et al., 2002). Given the important role of GPIb and integrin
IIbß3 in promoting plateletplatelet adhesion contacts necessary for thrombus growth, these findings raise the interesting possibility that calcium signals downstream of these receptors also play an important role in the process of platelet aggregation. Consistent with this possibility are recent studies by Kuwahara et al. (1999), who demonstrated a potentially important role for integrin
IIbß3dependent calcium flux in promoting platelet aggregation and thrombus growth on vWf.
In this study, we have employed a confocal imaging technique that enables real-time analysis of platelet calcium flux during thrombus formation. Application of this technique to an in vitro thrombosis model demonstrates that stable adhesion contact formation between aggregating platelets is dependent on the efficient communication of calcium signals between adherent platelets, a process we refer to as intercellular calcium communication (ICC). ICC is primarily mediated by the cooperative interplay between integrin
IIbß3 engagement and ADP activation of the recently cloned purinergic receptor P2Y12. We demonstrate that the coordination of calcium flux through plateletplatelet contacts serves to propagate the calcium signal throughout the developing thrombus, thereby driving thrombus growth.
| Results |
|---|
|
|
|---|
0.6 s), at the point when the primary adherent cell is expressing peak
[Ca2+]c (Fig. 2 D). Thus, the efficiency by which the platelet activation status is propagated by ICC is not only dependent on plateletplatelet contacts per se, but also on the timing of tether formation with
[Ca2+]c maxima. These studies suggest a potentially important role for ICC in dynamically regulating platelet accrual onto the surface of developing thrombi.
|
|
IIbß3
IIbß3 in promoting cytosolic calcium flux during platelet adhesion and aggregation on immobilized vWf (Kuwahara et al., 1999; Nesbitt et al., 2002). To examine the importance of integrin
IIbß3 in promoting ICC, calcium dyeloaded platelets were allowed to adhere to a vWf matrix, and an initial population of stably adherent platelets undergoing calcium oscillations was established. A second population of platelets treated with control buffer or the integrin
IIbß3 antagonist, aggrastat, were subsequently perfused at a shear rate of 1,800 s-1 over this adherent population. A significant advantage of this two-step adhesion assay was the ability of the primary adherent population of platelets to elicit a sustained calcium signal in the presence of integrin
IIbß3 antagonists, presumably because the ligated integrins on the basal surface of spreading platelets were not accessible to the inhibitor. As demonstrated in Fig. 2 A, ICC still occurred under these experimental conditions. However, blocking ligand binding to integrin
IIbß3 with aggrastat or c7E3 completely eliminated ICC without affecting the ongoing calcium signal in the primary adherent platelet population (Fig. 2 B). In control studies, pretreatment of the flowing population of platelets with the
-
2ß1blocking IgG BHA2.1 had no effect on ICC or aggregation at the surface of immobilized vWf, demonstrating that ICC was specific to integrin
IIbß3 engagement (Fig. 2 C).
ICC requires secreted ADP
The release of ADP from platelet-dense granules has a well-established role in promoting platelet aggregation in response to multiple physiological agonists, including vWf (Moritz et al., 1983; Peterson et al., 1987; Moake et al., 1988; Ikeda et al., 1991; Chow et al., 1992; Oda et al., 1995; Gachet, 2001). To investigate the contribution of secreted ADP to ICC, platelet calcium dynamics were examined during platelet adhesion and aggregation on a vWf matrix in the presence of the ADP-scavenging enzyme apyrase (1.5 U/ml ADPase activity). Consistent with previous findings, primary adherent platelets could elicit a sustained oscillatory calcium response in the presence of 1.5 U/ml apyrase (Nesbitt et al., 2002) (Fig. 3 A). However, the ability of these primary adherent cells to act as nuclei for subsequent ICC was completely blocked (Fig. 3 A), resulting in an inability of platelets to form stable aggregates. Similarly, pretreating platelets with the specific purinergic receptor antagonists, A3P5PS and AR-C69931MX in combination, to selectively inhibit both the P2Y1 and P2Y12 receptors, respectively, (Boyer et al., 1996; Ingall et al., 1999; Humphries, 2000) also completely eliminated ICC and platelet aggregate formation on vWf (unpublished data). Further examination of the individual contribution of the P2Y1 and P2Y12 signaling pathways demonstrated that blockade of ADP binding to the P2Y1 receptor alone had no effect on ICC and did not inhibit platelet aggregate formation (Fig. 3 B). Specific blockade of the P2Y12 receptor with 200 nM AR-C69931MX did not inhibit the initial calcium spiking associated with plateletplatelet contact (Fig. 3, C and D, dotted mark), but did completely inhibit ongoing/oscillatory ICC and stable aggregation (Fig. 3 C). The demonstration that P2Y12 blockade still allowed for a transient ICC spike suggested that the P2Y1 signaling pathway may be involved in initiating early calcium spiking events associated with plateletplatelet contact. Alternatively, the transient calcium spike observed in the presence of P2Y12 blockade alone may have been triggered by the release of a secondary secreted agonist, such as thromboxane A2 (TXA2). To examine this possibility, platelets were pretreated with 1.5 mM aspirin before perfusion over the surface of immobilized vWf. Although 1.5 mM aspirin was found to completely inhibit platelet aggregation responses to arachidonic acid (unpublished data), this treatment did not have any effect on initial platelet adhesive events nor on ICC at the surface of vWf under flow conditions (unpublished data). These studies indicate that activation of the P2Y12 purinergic receptor pathway is a key event in the establishment of effective ICC and platelet aggregation.
|
IIbß3 act in a cooperative manner to promote sustained calcium flux and firm platelet adhesion under flow
IIbß3 cooperate to drive cytosolic calcium flux in aggregating platelets, we examined the effect of exogenous ADP addition on cytosolic calcium flux during platelet adhesion to vWf. As demonstrated in Fig. 4 A, in the absence of added ADP, <6% of tethered platelets formed stationary adhesion contacts and elicited a sustained (>30 s) calcium response on a vWf matrix (1,800 s-1). We have previously demonstrated that this oscillatory calcium flux is dependent on integrin
IIbß3 outside-in signaling, as it is completely inhibited by c7E3 Fab, but not by ADP and TXA2 antagonists (Nesbitt et al., 2002). Exposure of platelets to soluble ADP during surface translocation on vWf resulted in a dramatic increase in the proportion of platelets forming stable adhesion contacts with the vWf surface (>90% of platelets), with all stably adherent platelets exhibiting sustained calcium oscillations (Fig. 4 B). The potentiating effect of ADP on the calcium response of translocating platelets was dependent on integrin
IIbß3, as it was completely prevented by blocking ligand binding with aggrastat (Fig. 4 C). These studies demonstrate an important cooperative signaling role for ADP and integrin
IIbß3, in which the latter receptor is essential for sustained cytosolic calcium flux.
|
110,000 µm3) typically form on collagen fibrils, coalescing to form extremely large platelet masses (Fig. 5 A). Real-time analysis of platelet adhesion at the surface of vWf demonstrated that only 6.5 ± 1.7% of platelets maintained stationary adhesion contacts for a period >30 s. In contrast, all platelets interacting with collagen fibrils formed immediate stationary adhesion contacts that provided highly efficient nuclei for the recruitment of additional platelets, resulting in the rapid formation of very large platelet aggregates.
|
[Ca2+]c (>100 nM) was 0.06 at the surface of vWf in comparison with 0.95 at the surface of type I collagen. Second, 53% of platelets tethering to primary adherent (calcium active) platelets at the surface of vWf underwent an oscillatory calcium response, with these platelets forming stable aggregates (Fig. 5 B). In contrast, efficient ICC occurred in 100% of platelets tethering to primary adherent cells at the surface of type I collagen (Fig. 5 B). Thus, the frequency of successful ICC/aggregation within the entire platelet population as a function of primary stationary adhesion and ICC efficiency was calculated to be 3.4% and 100% at the surface of vWf and type 1 collagen, respectively. It should be noted that in all studies (>100 independent experiments), there was a strict correlation between cytosolic calcium flux in the primary adherent layer of platelets and the propensity of these cells to act as nuclei for platelet aggregate formation. Furthermore, on both the vWf and collagen matrices, chelating cytosolic calcium by pretreating platelets with the high-affinity calcium chelator DM-BAPTA-AM completely eliminated calcium oscillations in the primary adherent cells and consequently inhibited platelet aggregation and thrombus growth (unpublished data). Finally, the mean and maximal
[Ca2+]c at the surface of vWf were low (mean 234.5 nM; max 796 nM) relative to collagen (mean 913.3 nM; max 1,974 nM) (Fig. 5, C and D). All of these parameters combined provide an explanation for the efficiency of platelet aggregate formation on a type I collagen substrate relative to vWf.
NP-EGTA uncaging triggers ICC events and platelet aggregation
Finally, to provide more direct evidence that changes in cytosolic calcium flux in the primary adherent layer of platelets impacts on the efficiency of platelet aggregation, we examined the effect of inducing a single transient calcium spike in translocating platelets. This was achieved by loading platelets with the caged calcium chelator NP-EGTA, which upon UV exposure results in a rapid, transient increase in cytosolic calcium (Nesbitt et al., 2002). A significant advantage of this experimental approach is that it enables rapid release of calcium in a discrete population of primary adherent platelets only, immediately before the formation of plateletplatelet adhesion contacts. This maximizes the possibility of coordinating the initiation of calcium flux with subsequent ICC and, furthermore, minimizes potential experimental artifacts associated with platelet preadhesion, such as exhausted ADP release. To investigate the effects of calcium uncaging on platelet aggregate formation, NP-EGTAloaded platelets were perfused through vWf-coated microcapillary tubes at physiological platelet concentrations (150 x 109/L) to increase the probability of plateletplatelet adhesion contact formation. Similar to our previous findings (Nesbitt et al., 2002), eliciting a transient calcium spike in platelets that were not interacting with other translocating platelets resulted in temporary arrest of these cells (unpublished data). In contrast, induction of a single calcium spike at the point of contact between two translocating platelets resulted in prolonged arrest of both cells, leading to the induction of a sustained oscillatory calcium flux. Moreover, these cells formed efficient nuclei for the recruitment of free-flowing platelets leading to ICC and the rapid formation of platelet aggregates (Fig. 6, A and B). Platelet aggregate formation and ICC under these experimental conditions were dependent on released ADP, as they were completely inhibited by pretreating the platelets with apyrase (Fig. 6 C) or a combination of both A3P5PS and AR-C6991MX (unpublished data). These findings provide further support for the concept that communication of calcium signals between platelets is important in regulating the efficiency of platelet aggregation under flow.
|
| Discussion |
|---|
|
|
|---|
IIbß3 engagement and ADP activation of the P2Y12 pathway. Our studies suggest that the efficiency of intercellular calcium signaling plays a major role in regulating the rate and extent of platelet thrombus growth.
Our studies highlight a synergistic signaling relationship between ADP and integrin
IIbß3 that serves to regulate cytosolic calcium flux during platelet aggregation. Our findings do not exclude a role for other soluble agonists, in particular thrombin and TXA2, in promoting calcium flux between aggregating platelets in vivo. Although, under the experimental conditions employed here, these agonists do not appear to be essential for ICC or platelet aggregation. It is likely that the efficiency of ICC and thrombus growth represents the cumulative effect of multiple activating stimuli, with ADP playing a major amplifying role in this process. In this context, it is well established that ADP alone, acting primarily through the P2Y1 and P2Y12 receptors, induces a transient calcium response that leads to relatively weak platelet stimulation (Born, 1962; MacFarlane, 1987; Gachet, 2001). In contrast, integrin
IIbß3 engagement of vWf can induce sustained calcium oscillations that promote irreversible platelet activation, albeit in a relatively small subpopulation of platelets. As demonstrated here, the combination of ADP and integrin
IIbß3 acts as a potent stimulus for platelet activation, leading to high, sustained calcium oscillations and irreversible adhesion in >90% of tethered platelets. This synergy between ADP and integrin
IIbß3, with respect to calcium signaling, contrasts markedly with previous platelet aggregation studies in which fibrinogen binding to integrin
IIbß3 was demonstrated to inhibit ADP-stimulated calcium flux (Rosado et al., 2001). Thus, the cooperative signaling mechanism described here may primarily operate during plateletsurface interactions.
Our current working model to explain the synergy between ADP and integrin
IIbß3 during platelet aggregate formation is described in Fig. 7. We propose that initial primary adhesion to immobilized vWf is dependent on a cooperative signaling mechanism operating between GPIb and integrin
IIbß3, in which integrin
IIbß3derived signals sustain calcium oscillations and mediate stable adhesion (Nesbitt et al., 2002). This initial adhesion and calcium signaling can occur independent of soluble agonist stimulation (Yap et al., 2000; Nesbitt et al., 2002), although, as demonstrated here, it is greatly potentiated by such stimuli. In contrast to primary adhesion, our studies suggest that GPIb and integrin
IIbß3 calcium signaling is insufficient to drive sustained calcium flux in subsequent layers of aggregating platelets, despite the fact that both receptors must engage platelet-expressed vWf for effective platelet aggregation under high shear flow conditions. The reason for this difference between primary adhesion and aggregating cells is not clear but may relate to a difference in the number of GPIb and integrin
IIbß3 adhesive bonds. For example, under the experimental conditions employed in this study, primary adherent platelets are exposed to a purified vWf substrate, providing a relatively high concentration of binding sites for GPIb and integrin
IIbß3. In aggregating platelets, the number of bonds formed between platelet-bound vWf, GPIb, and integrin
IIbß3 may be limiting, thereby reducing platelet activation signals downstream of these receptors and explaining the requirement for soluble ADP.
|
IIbß3derived calcium signals by a P2Y12-linked signaling mechanism. In this context, it was somewhat surprising that inhibition of the P2Y1 receptor did not have a major effect on ICC, given the well-established role of this receptor in promoting transient calcium signaling. The demonstration that either GPIb or integrin
IIbß3 can elicit cytosolic calcium signals may partly explain the dispensable role for the P2Y1 receptor in this process. An important element of the current model that requires further investigation is the relationship between integrin
IIbß3 ligation and ADP release. Although purely speculative, an attractive hypothesis is that transient integrin
IIbß3 engagement of vWf promotes release of ADP in the immediate vicinity of plateletplatelet adhesion contacts, coordinating localized platelet activation. This form of spatial signaling provides a mechanism for achieving high local concentrations of excitatory signals during cellcell contact that may counteract, at least in part, the rapid clearance of soluble stimuli by flowing blood.
A long-standing unresolved issue is the mechanism by which an adhesive substrate that only interacts with the primary adherent layer of platelets propagates activating signals to regulate the reactivity of integrin
IIbß3 in subsequent layers of aggregating platelets. The phenomenon of ICC elucidated in the present study provides new insight into this mechanism. We demonstrate that differences in the calcium flux profiles of primary adherent platelets at the surface of vWf and collagen correlate directly with the efficiency by which these substrates support platelet aggregation and thrombus growth. Our studies suggest that the frequency and magnitude of calcium flux in the primary layer of adherent platelets play a major role not only in regulating the dynamics of primary platelet adhesion (Nesbitt et al., 2002) but also in subsequent platelet aggregation and thrombus growth.
Intercellular calcium signaling is a widespread form of cellcell communication that allows tissue coordination of cell proliferation, differentiation, and metabolism. ICC has been described in many cell types, including osteoblasts (Jorgensen et al., 2000; Romanello et al., 2001; Saunders et al., 2001), chondrocytes (Tonon and D'Andrea, 2000; Elfervig et al., 2001), astrocytes (Guthrie et al., 1999; Fam et al., 2000; Rouach et al., 2000; Schemes, 2000; Shiga et al., 2001; Verderio and Metteoli, 2001), oligodendrocytes (Verderio and Metteoli, 2001), neurons (Guthrie et al., 1999; Fam et al., 2000; Rouach et al., 2000; Schemes, 2000), endothelial cells (Moerenhout et al., 2001a,b), and retinal epithelial cells (Himpens et al., 1999; Himpens and Vereecke, 2000). Several distinct mechanisms have been demonstrated to coordinate calcium signaling between cells, including autocrine activation of P2 purinergic receptors, leading to calcium release from intracellular stores (Churchill and Louis, 1998; Fam et al., 2000; Jorgensen et al., 2000; Elfervig et al., 2001; Verderio and Metteoli, 2001). The results presented here demonstrate, for the first time, the involvement of an integrin in this process and, furthermore, establish an important role for cooperative signaling between integrin
IIbß3 and purinergic receptors in regulating the three-dimensional growth of developing thrombi.
| Materials and methods |
|---|
|
|
|---|
-VLA-2 (
2ß1)blocking IgG BHA2.1 was obtained from Chemicon International. Apyrase was purified from potatoes according to the method of Molnar and Lorand (1961) and was a generous gift from Francois Lanza (Institut National de la Santé et de la Recherche Médicale, Strasbourg, France). Human vWf was purified to homogeneity from plasma cryoprecipitate according to the methods of Montgomery and Zimmerman (1978). All other reagents were obtained from sources described previously (Yuan et al., 1997; Cranmer et al., 1999).
Platelet isolation and reconstitution with RBCs
Anticoagulated whole blood (15 mM trisodium citrate, pH 7.4) was collected from healthy volunteers that had not received any antiplatelet medication in the preceding 2 wk. Platelet isolation was performed according to Yuan et al. (1997), and washed platelets were finally resuspended in modified Tyrode's buffer (10 mM Hepes, 12 mM NaHCO3, pH 7.4, 137 mM NaCl, 2.7 mM KCl, 5 mM glucose) supplemented with 1 mM CaCl2/MgCl2 or 1 mM EGTA/MgCl2 where indicated. Autologous RBCs were prepared according to Yap et al. (2000). Before reconstitution with isolated platelets (50% vol/vol hematocrit), isolated RBCs were treated with 0.4 U/ml apyrase (ADPase activity) and 1 U/ml hirudin (Yap et al., 2000).
Flow-based platelet adhesion assays
Flow assays were performed using glass microcapillary tubes (Microslides; Vitro Dynamics Inc.) coated with human vWF (100 µg/ml) according to a modified method of Cooke et al. (1993). Oregon green BAPTA-1/Fura redloaded platelets were reconstituted with isolated autologous RBCs (50% hematocrit) and either Tyrode's supplemented with 1 mM Ca2+/Mg2+ or EGTA/Mg2+ and perfused through human vWF microcapillaries blocked with 10% heat-inactivated human serum at a shear rate of 1,800 s-1. The first 3 min of platelet flow was captured as a sequential 37.5-s series (0.586 frames per second capture rate) via confocal microscopy and Leica acquisition software for off-line analysis.
Analysis of platelet calcium flux
Platelet calcium flux was monitored as previously described by Yap et al. (2000). Isolated platelets (1.5 x 109/ml) suspended in PWB (10 mM Hepes, pH 7.4, 140 mM NaCl, 5 mM glucose) were incubated for 30 min at 37°C with Oregon green BAPTA-1, AM (1 µM) and Fura red, AM (1.25 µM). Unincorporated dye was removed by washing twice with PWB. Platelets were subsequently resuspended in Tyrode's buffer containing either 1 mM Ca2+/Mg2+ or 1 mM EGTA/Mg2+. Real-time platelet calcium flux was monitored via confocal microscopy as the ratio of Oregon green BAPTA-1 fluorescence over Fura red fluorescence (with emission wavelengths of 500570 nm and 600710 nm, respectively). Fluorescence ratios were converted to relative cytosolic calcium concentration (
[Ca2+]c) according to Equation 1:
![]() | (1) |
[Ca2+]c to indicate that all calcium concentration estimates are relative to a zero point set by DM-BAPTA calcium chelation.
In vitro thrombus assay
Microcapillaries were coated with type I equine tendon fibrillar collagen (2.5 mg/ml) overnight at 4°C. Platelet thrombi were allowed to form on collagen after perfusion for 10 min of washed platelets reconstituted with autologous RBCs (50% hematocrit) and plasma (Fig. 2 A). Washed platelets loaded with the calcium-responsive dyes Oregon BAPTA and Fura red were perfused through the microcapillary tubes subsequent to thrombus formation. A single confocal section
1 µm deep was taken at least 10 µm from the collagen matrix surface. The first 3 min of platelet flow within this focal plane was captured as a sequential 37.5-s series (0.586 frames per second capture rate) and analyzed off line using Leica physiology software.
NP-EGTA "caged calcium" assay
Isolated human platelets were loaded with Oregon green BAPTA and Fura red as per established protocol. Calcium dyeloaded platelets were subsequently incubated in PWB with 10 µM NP-EGTA (Molecular Probes) for 30 min at 37°C as per Nesbitt et al. (2002). NP-EGTAtreated platelets were subsequently washed once with PWB and resuspended in PWB before experimentation. The behavior of NP-EGTAloaded platelets was assessed under flow conditions (1,800 s-1) at the surface of immobilized human vWf (100 µg/ml) as per established protocols. NP-EGTAloaded platelets exhibited translocation and adhesive properties equivalent to untreated controls. NP-EGTA uncaging was performed after 18 s of reconstituted blood flow via exposure of platelets to a near-UV (300400 nm) light source generated by a 100-W Hg lamp directed through the optical path of a Leica DMIRBE confocal microscope for a period of 0.6 s. Control studies were performed with unloaded control platelets and demonstrated that the brief (0.6 s) UV exposure did not lead to photodynamic damage or activation of the platelets under flow.
Online supplemental material
A supplemental video (Video 1) is available online at http://www.jcb.org/cgi/content/full/jcb.200207119/DC1. This movie file presents real-time intercellular calcium flux during plateletvWf and plateletplatelet interactions during perfusion of reconstituted blood at a shear rate of 1,800 s-1.
| Acknowledgments |
|---|
This project was supported by funding from the National Health and Medical Research Council, The National Heart Foundation, and The Wellcome Trust.
Submitted: 26 July 2002
Revised: 13 February 2003
Accepted: 13 February 2003
| References |
|---|
|
|
|---|
Badimon, L., J.J. Badimon, V.T. Turitto, and V. Fuster. 1989. Role of von Willebrand factor in mediating platelet-vessel wall interaction at low shear rate: The importance of perfusion conditions. Blood. 73:961967.
Baumgartner, H.R., T.B. Tschopp, and H.J. Weiss. 1977. Platelet interaction with collagen fibrils in flowing blood. II. Impaired adhesion-aggregation in bleeding disorders. A comparison with subendothelium. Thromb. Haemost. 37:1728.[Medline]
Born, G.V.R. 1962. Aggregation of platelets with adenosine diphosphate and its reversal. Nature. 194:2729.[CrossRef][Medline]
Boyer, J.L., T. Romero-Avila, J.B. Schachter, and T.K. Harden. 1996. Identification of competitive antagonists of the P2Y1 receptor. Mol. Pharmacol. 50:13231329.[Abstract]
Chow, T.W., J.D. Hellums, J.L. Moake, and M.H. Kroll. 1992. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood. 80:113120.
Churchill, G.C., and C.F. Louis. 1998. Roles of Ca2+, inositol triphosphate and cyclic ADP-ribose in mediating intercellular Ca2+ signalling in sheep lens cells. J. Cell Sci. 111:12171225.[Abstract]
Clemetson, K.J., and J.M. Clemetson. 2001. Platelet collagen receptors. Thromb. Haemost. 86:189197.[Medline]
Cooke, B.M., S. Usami, I. Perry, and G.B. Nash. 1993. A simplified method for culture of endothelial cells and analysis of adhesion of blood cells under conditions of flow. Microvasc. Res. 45:3355.[CrossRef][Medline]
Cranmer, S.L., P. Ulsemer, B.M. Cooke, H.H. Salem, C. de la Salle, F. Lanza, and S.P. Jackson. 1999. Glycoprotein (GP) Ib-IX-transfected cells roll on a von Willebrand factor matrix under flow. Importance of the GP Ib/actin-binding protein (ABP-280) interaction in maintaining adhesion under high shear. J. Biol. Chem. 274:60976106.
Denis, C.V., N. Methia, P.S. Frenette, H. Rayburn, M. Ullman-Cullere, R.O. Hynes, and D.D. Wagner. 1998. A mouse model of severe von Willebrand's disease: defects in haemostasis and thrombosis. Proc. Natl. Acad. Sci. USA. 95:95249529.
Denis, C.V., P. Andre, S. Saffaripour, and D.D. Wagner. 2001. Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor deficient mice. Proc. Natl. Acad. Sci. USA. 98:40724077.
Elfervig, M.K., R.D. Graff, G.M. Lee, S.S. Kelley, A. Sood, and A.J. Banes. 2001. ATP induces Ca2+ signalling in human chondrons cultured in three dimensional agarose films. Osteoarthritis Cartilage. 9:518525.[CrossRef][Medline]
Fam, S.R., C.J. Gallagher, and M.W. Salter. 2000. P2Y1 purinoceptormediated Ca2+ signaling and Ca2+ wave propagation in dorsal spinal cord astrocytes. J. Neurosci. 20:28002808.
Fuster, V., and J.H. Chesebro. 1986. Mechanisms of unstable angina. N. Engl. J. Med. 315:10231025.[Medline]
Gachet, C. 2001. ADP receptors of platelets and their inhibition. Thromb. Haemost. 86:222232.[Medline]
Goto, S., Y. Ikeda, E. Saldivar, and Z.M. Ruggeri. 1998. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J. Clin. Invest. 101:479486.[Medline]
Guthrie, P.B., J. Knappenberger, M. Segal, M.V. Bennett, A.C. Charles, and S.B. Kater. 1999. ATP released from astrocytes mediates glial calcium waves. J. Neurosci. 19:520528.
Himpens, B., and J. Vereecke. 2000. Intra and intercellular Ca(2+)-signal transduction. Verh. K. Acad. Geneesskd. Belg. 62:501563.
Himpens, B., P. Stahlmans, P. Gomez, M. Malfait, and J. Vereecke. 1999. Intra- and intercellular calcium signaling in retinal pigment epithelial cells during mechanical stimulation. FASEB J. 13:S63S68.
Humphries, R.G. 2000. Pharmacology of AR-C69931MX and related compounds: from pharmacological tools to clinical trials. Haematologica. 85:6672.[Medline]
Ikeda, Y., M. Handa, K. Kawano, T. Kamata, M. Murata, Y. Araki, H. Anbo, Y. Kawai, K. Watanabe, and I. Itagaki. 1991. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J. Clin. Invest. 87:12341240.[Medline]
Ingall, A.H., J. Dixon, A. Bailey, M.E. Coombs, D. Cox, J.I. McInally, S.F. Hunt, N.D. Kindon, B.J. Teobald, P.A. Willis, et al. 1999. Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. J. Med. Chem. 42:213220.[CrossRef][Medline]
Jander, S., M. Sitzer, A. Wendt, M. Schroeter, M. Buchkremer, M. Siebler, W. Muller, W. Sandmann, and G. Stoll. 2001. Expression of tissue factor in high grade carotid artery stenosis: association with plaque destabilisation. Stroke. 32:850854.
Jorgensen, N.R., Z. Henriksen, C. Brot, E.F. Eriksen, O.H. Sorensen, R. Civitelli, and T.H. Steinberg. 2000. Human osteoblastic cells propagate intracellular calcium signals by two different mechanisms. J. Bone Miner. Res. 15:10241032.[CrossRef][Medline]
Kulkarni, S., S.M. Dopheide, C.L. Yap, C. Ravanat, C. Freund, P. Mangin, K.A. Heel, A. Street, I.S. Harper, F. Lanza, and S.P. Jackson. 2000. A revised model of platelet aggregation. J. Clin. Invest. 105:783791.[Medline]
Kuwahara, M., M. Sugimoto, S. Tsuji, S. Miyata, and A. Yoshioka. 1999. Cytosolic calcium changes in a process of platelet adhesion and cohesion on a von Willebrand factor-coated surface under flow conditions. Blood. 94:11491155.
MacFarlane, D.E. 1987. Agonists and receptors: adenosine diphosphate. Platelet Responses and Metabolism. H. Holmsen, editor. CRC Press, Boca Raton, Florida. 1936.
Mazzucato, M., P. Spessotto, A. Masotti, L. De Appollonia, M.R. Cozzi, A. Yoshioka, R. Perris, A. Colombatti, and L. De Marco. 1999. Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flow. J. Biol. Chem. 274:30333041.
Moake, J.L., N.A. Turner, N.A. Stathopoulos, L. Nolasco, and J.D. Hellums. 1988. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood. 71:13661374.
Moerenhout, M., B. Himpens, and J. Vereecke. 2001a. Intercellular communication upon mechanical stimulation of CPAE-endothelial cells is mediated by nucleotides. Cell Calcium. 29:125136.[CrossRef][Medline]
Moerenhout, M., J. Vereecke, and B. Himpens. 2001b. Mechanism of intracellular calcium wave propagation elicited by mechanical stimulation in cultured endothelial CPAE cells. Cell Calcium. 29:117123.[CrossRef][Medline]
Molnar, J., and L. Lorand. 1961. Studies on apyrases. Arch. Biochem. Biophys. 93:353363.[CrossRef][Medline]
Montgomery, R.R., and T.S.J. Zimmerman. 1978. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease. J. Clin. Invest. 61:14981507.[Medline]
Moritz, M.W., R.C. Reimers, R.K. Baker, S.P. Sutera, and J.H. Joist. 1983. Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress. J. Lab. Clin. Med. 101:537544.[Medline]
Nesbitt, W.S., S. Kulkarni, S. Giuliano, I. Goncalves, S.M. Dopheide, C.L. Yap, I.S. Harper, H.H. Salem, and S.P. Jackson. 2002. Distinct glycoprotein Ib/V/IX and integrin
IIbß3-dependent calcium signals cooperatively regulate platelet adhesion under flow. J. Biol. Chem. 277:29652972.
Ni, H., C.V. Denis, S. Subbarao, J.L. Degen, T.N. Sato, R.O. Hynes, and D.D. Wagner. 2000. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J. Clin. Invest. 106:385392.[Medline]
Oda, A., K. Yokoyama, M. Murata, M. Tokuhira, K. Nakamura, M. Handa, K. Watanabe, and Y. Ikeda. 1995. Protein tyrosine phosphorylation in human platelets during shear stress-induced platelet aggregation (SIPA) is regulated by glycoprotein (GP) Ib/IX as well as GP IIb/IIIa and requires intact cytoskeleton and endogenous ADP. Thromb. Haemost. 74:736742.[Medline]
Peterson, D.M., N.A. Stathopoulos, T.D. Giorgio, J.D. Hellums, and J.L. Moake. 1987. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 69:625628.
Romanello, M., L. Moro, D. Pirulli, S. Crovella, and P. D'Andrea. 2001. Effects of cAMP on intercellular coupling and osteoblast differentiation. Biochem. Biophys. Res. Commun. 282:11381144.[CrossRef][Medline]
Rosado, J.A., E.M.Y. Meijer, K. Hamulak, I. Novakova, J.W.M. Heemskerk, and S.O. Sage. 2001. Fibrinogen binding to the integrin
IIbß3 modulates store mediated calcium entry in human platelets. Blood. 97:26482656.
Rouach, N., J. Glowinski, and C. Giaume. 2000. Activity-dependent neuronal control of gap-junctional communication in astrocytes. J. Cell Biol. 149:15131526.
Ruggeri, Z.M. 1993. Mechanisms of shear induced platelet adhesion and aggregation. Thromb. Haemost. 70:119123.[Medline]
Ruggeri, Z.M., J.A. Dent, and E. Saldivar. 1999. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood. 94:172178.
Ruggeri, Z.M. 2000. Role of von Willebrand factor in platelet thrombus formation. Ann. Med. 32(Suppl. 1): 29.
Saunders, M.M., J. You, J.E. Trosko, H. Yamasaki, Z. Li, H.J. Donahue, and C.R. Jacobs. 2001. Gap junctions and fluid flow response in MC3T3-E1 cells. Am. J. Physiol. Cell Physiol. 281:C1917C1925.
Savage, B., E. Saldivar, and Z.M. Ruggeri. 1996. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 84:289297.[CrossRef][Medline]
Savage, B., F.A. Jacobs, and Z.M. Ruggeri. 1998. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 94:657666.[CrossRef][Medline]
Schemes, E. 2000. Components of astrocytic intercellular calcium signaling. Mol. Neurobiol. 22:167179.[CrossRef][Medline]
Shiga, H., T. Tojima, and E. Ito. 2001. Ca2+ signalling regulated by an ATP-dependent autocrine mechanism in astrocytes. Neuroreport. 12:26192622.[CrossRef][Medline]
Tonon, R., and P. D'Andrea. 2000. Interleukin-1ß increases the functional expression of connexin 43 in articular chondrocytes: evidence for a Ca2+-dependent mechanism. J. Bone Miner. Res. 15:16691677.[CrossRef][Medline]
Toschi, V., R. Gallo, M. Lettino, J.T. Fallon, S.D. Gertz, A. Fernandez-Ortiz, J.H. Chesebro, L. Badimon, Y. Nemerson, V. Fuster, and J.J. Badimon. 1997. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 95:594599.
Tsuji, S., M. Sugimoto, S. Miyata, M. Kuwahara, S. Kinoshita, and A. Yoshioka. 1999. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood. 94:968975.
Van Zanten, G.H., S. de Graaf, P.J. Slootweg, H.F. Heijnen, T.M. Connolly, P.G. de Groot, and J.J. Sixma. 1994. Increased platelet deposition on atherosclerotic coronary arteries. J. Clin. Invest. 93:615632.[Medline]
Verderio, C., and M. Metteoli. 2001. ATP mediates calcium signalling between astrocytes and microglial cells: modulation by INF-
. J. Immunol. 166:63836391.
Weiss, H.J., J. Hawiger, Z.M. Ruggeri, V.T. Turitto, P. Thiagarajan, and T. Hoffmann. 1989. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J. Clin. Invest. 83:288297.[Medline]
Wilcox, J.N., K.M. Smith, S.M. Schwartz, and D. Gordon. 1989. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc. Natl. Acad. Sci. USA. 86:28392843.
Yap, C.L., S.C. Hughan, S.L. Cranmer, W.S. Nesbitt, M.M. Rooney, S. Giuliano, S. Kulkarni, S.M. Dopheide, Y. Yuan, H.H. Salem, and S.P. Jackson. 2000. Synergistic adhesive interactions and signalling mechanisms operating between platelet glycoprotein Ib/V/IX and integrin
IIbß3. J. Biol. Chem. 275:4137741388.
Yuan, Y., S.M. Dopheide, C. Ivanidis, H.H. Salem, and S.P. Jackson. 1997. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factorstimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin
IIbß3) in von Willebrand factorinduced signal transduction. J. Biol. Chem. 272:2184721854.
Related Article
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|